Caris Life Sciences Highlights Gene Expression Profiling Findings at 12th Annual International Congress of Human Genetics

IRVING, Texas, Oct. 18, 2011 (GLOBE NEWSWIRE) -- Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling and blood-based diagnostic services, presented at the 12th International Congress of Human Genetics (ICHG). Caris presented clinical data that demonstrates microarray analysis is a reliable and robust method to perform gene expression profiling on routine solid tumor samples. The data provides further support for the quality and clinical utility of information generated by evidence-based molecular profiling services like Caris Target Now.